Top 50 Life Science VC Funds & Investors in United Kingdom (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Parkwalk Advisors
VC Fund
|
23 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.2M–$45M |
|
UK Innovation & Science Seed Fund
VC Fund
|
16 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $458k–$14M |
|
Oxford Science Enterprises
VC Fund
|
16 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.4M–$168M |
|
SOSV
VC Fund
|
13 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
IQ Capital
VC Fund
|
11 | United Kingdom, United States, Germany | Seed, Series A | Software, Artificial Intelligence, Machine Learning | $1.3M–$40M |
|
Development Bank of Wales
VC Fund
|
10 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Manufacturing | $18k–$3.8M |
|
Syncona Partners LLP
VC Fund
|
9 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.8M–$156M |
|
Selvedge Venture
VC Fund
|
9 | United Kingdom, United States, Canada | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $1.1M–$30M |
|
Sofinnova Partners
VC Fund
|
9 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Maven Capital Partners
VC Fund
|
8 | United Kingdom, United States, Germany | Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $655k–$8.8M |
|
24 Haymarket
VC Fund
|
8 | United Kingdom, United States | Seed, Series A | Health Care, Software, Biotechnology | $714k–$16M |
|
Scottish Enterprise
VC Fund
|
8 | United Kingdom, United States, Switzerland | Grant, Seed | Biotechnology, Software, Health Care | $119k–$4.3M |
|
O2h Ventures
VC Fund
|
7 | United Kingdom, Hungary | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
GM&C Life Sciences Fund
VC Fund
|
7 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $131k–$4.1M |
|
Future Planet Capital
VC Fund
|
7 | United Kingdom, United States, Spain | Seed, Convertible Note | Biotechnology, Health Care, Software | $688k–$5.5M |
|
Kindred Capital
VC Fund
|
6 | United Kingdom, United States, Germany | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1.5M–$73M |
|
Archangels
VC Fund
|
6 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $1.3M–$8.3M |
|
Newable Private Investing
VC Fund
|
6 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.2M |
|
Techstart Ventures
VC Fund
|
6 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $100k–$4M |
|
Angels in MedCity
VC Fund
|
6 | United Kingdom, United States | Seed, Angel | Health Care, Biotechnology, Medical | $458k–$880k |
|
Calculus Capital
VC Fund
|
6 | United Kingdom, United States, Ireland | Series A, Seed | Biotechnology, Software, Medical | $2M–$18M |
|
Google Ventures
VC Fund
|
5 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$125M |
|
Verve Ventures
VC Fund
|
5 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $1.4M–$45M |
|
Deepbridge Capital
VC Fund
|
5 | United Kingdom, Spain, Australia | Seed, Series A | Health Care, Biotechnology, Medical | $152k–$15M |
|
APEX Ventures
VC Fund
|
5 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$28M |
|
Scottish Investment Bank
VC Fund
|
5 | United Kingdom, United States, France | Seed, Series A | Software, Biotechnology, Health Care | $327k–$7.5M |
|
IP Group
VC Fund
|
5 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$30M |
|
Northstar Ventures
VC Fund
|
5 | United Kingdom, United States, Indonesia | Seed, Series A | Software, Health Care, E-Commerce | $39k–$10M |
|
Amadeus Capital Partners
VC Fund
|
5 | United Kingdom, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $900k–$60M |
|
SR One
VC Fund
|
5 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.7M–$175M |
|
Epidarex Capital
VC Fund
|
5 | United Kingdom, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $531k–$48M |
|
Formic Ventures
VC Fund
|
5 | United States, United Kingdom, Hong Kong | Seed, Series A, Series B | Biotechnology, Health Care, Pharmaceutical | $1.3M–$61M |
|
Fifty Years
VC Fund
|
4 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Artificial Intelligence | $2M–$91M |
|
Cambridge Innovation Capital
VC Fund
|
4 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$73M |
|
Catapult Ventures
VC Fund
|
4 | United Kingdom, United States, Israel | Seed, Series A | Health Care, Biotechnology, Medical | $150k–$26M |
|
Oxford Capital
VC Fund
|
4 | United Kingdom, United States, France | Seed, Series A | Software, Health Care, Biotechnology | |
|
Advent Life Sciences
VC Fund
|
4 | United States, United Kingdom, France | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$105M |
|
Angels 5K
VC Fund
|
4 | United Kingdom | Seed, Angel | Biotechnology, Software, Medical | $79k–$1.3M |
|
11.2 Capital
VC Fund
|
4 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Biotechnology | $1M–$53M |
|
Delin Ventures
VC Fund
|
4 | United Kingdom, Germany, Hungary | Seed, Series A, Series B | Software, Biotechnology, Information Technology | $1.3M–$100M |
|
Northern Gritstone
VC Fund
|
4 | United Kingdom, Singapore | Seed, Series A, Series D | Software, Electronics, Health Care | $2.4M–$229M |
|
Discovery Park
VC Fund
|
4 | United Kingdom, Germany, United States | Non-Equity Assistance, Pre-Seed, Seed | Biotechnology, Life Science, Energy | $391k–$1.7M |
|
Octopus Ventures
VC Fund
|
4 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$44M |
|
SFC Capital
VC Fund
|
4 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $131k–$2.2M |
|
Playfair Capital
VC Fund
|
4 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $700k–$18M |
|
Molten Ventures
VC Fund
|
4 | United Kingdom, United States, Germany | Series A, Series B | Software, Information Technology, FinTech | $3.2M–$60M |
|
Episode 1
VC Fund
|
4 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1M–$20M |
|
Pentech Ventures
VC Fund
|
4 | United Kingdom, United States, Ireland | Series A, Series B | Software, Information Technology, Analytics | $1.3M–$60M |
|
Brandon Capital
VC Fund
|
4 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
Ada Ventures
VC Fund
|
4 | United Kingdom, Denmark, Ireland | Seed, Pre-Seed | Software, Artificial Intelligence, Health Care | $507k–$6.8M |
| Access all 662 VC funds in United Kingdom Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 289
- Round size: Seed $1.2M–$4.8M; Series A $1.6M–$15M; Series B $2M–$45M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Psyomics — Technology to support better mental health assessment - accelerating patients to the right care pathway, first time.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 144
- Round size: Seed $458k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- MFX — MFX develops microfluidic-based platforms for cell and gene therapy development and manufacturing
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 195
- Round size: Seed $1.4M–$12M; Series A $6.3M–$45M; Series B $13M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $327M in 2022
Portfolio highlights
- AlveoGene — Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Scripta Therapeutics — Biology decoded, disease undone - modulating transcription factors to restore health
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 205
- Round size: Seed $1.3M–$12M; Series A $4.5M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
- Dataswyft — Infrastructure for Decentralized Data Storage, Mobility and Interoperability
- Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 248
- Round size: Seed $360k–$3.3M; Debt Financing $18k–$3.8M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Wagonex — Car subscription is the new, all-inclusive, flexible alternative to leasing. No large downpayment and a single fixed monthly payment. Just add fuel and go.
- Jehu Group — The Jehu Group is a third generation family owned business with over 80 years of successful trading history.We mange our operations on a day-to-day basis through three trading subsidiaries. Each subsidiary is supported by Jehu Group Limited which provides finance, HR, technical and procurement functions.In all of our markets, we position ourselvesas a dynamic and bespoke alternative to national contractors and house builders and are proud of our strong reputation in the market place.
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 69
- Round size: Seed $1.8M–$17M; Series A $13M–$110M; Series B $29M–$156M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 20
- Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
- BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
- MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 329
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 205
- Round size: Seed $655k–$5.3M; Venture - Series Unknown $1.4M–$8.8M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- HubIsoft Group — A new class of data technology. You drive, decide where you go and how you navigate, explore areas you thought unfathomable, you are in complete control.
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 107
- Round size: Seed $714k–$3.8M; Series A $1.6M–$16M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
- Kelda Technology — Kelda Technology is a British clean tech business that develops water-in-air shower products that halve water usage and water heating costs through patented shower technology. Kelda Technology has adapted cutting edge automotive and aerospace technology to produce a revolutionary “water-in-air” shower system that halves water use without any lossin performance. Water is broken into droplets to form a comfortable spray which is accelerated using a globally patented jet-type nozzle. Not only does it halve water costs, but also halves associated heating costs.The Kelda shower system holds appeal for a wide range of sectors, including gym and leisure, hotels and accommodation providers, healthcare, and maritime – all industries where water efficiency is key. The product has completed in-market validation and commercial trials, is in manufacture and the company has already signed installation deals with some of the largest leisure operators in the UK and Latin America.Kelda Technology was recently chosen as one of the top 30 cleantech companies in the world at the New Energy Start-Up awards 2016 and was this week shortlisted by the UK Business Angels Association for Best Investment in a Disruptive Tech Business.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 386
- Round size: Seed $381k–$4.3M; Grant $119k–$4.2M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
- Cirrus Logic — Cirrus Logic, Inc. is a premier supplier of high-precision analog and digital signal processing components for audio and energy markets.Founded in 1984, Cirrus Logic excels at developing complex chip designs where feature integration and innovation is a premium. Cirrus Logic has more than 1,000 patents that are key to our more than 700 productsserving more than 2,500 end customers globally, through both direct and distributor-based channel sales.
- Incremental Group — Incremental Group provides software consultancy and analytics services to clients in oil and gas, financial services, and the public sector.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 49
- Round size: Seed $603k–$7.5M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 34
- Round size: Seed $131k–$1.9M; Series A $1.8M–$4.1M
- Lead/follow: 68% lead, 32% follow
Portfolio highlights
- Gendius — Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focussesthe individual on clinically validated tasks and measures to slow their progression in these areas.
- Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
- Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 181
- Round size: Seed $688k–$5.5M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
A new model for Venture Capital where every founder we back becomes a co-owner of the fund.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 118
- Round size: Seed $1.5M–$18M; Series A $7.9M–$35M; Series B $13M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- BEIT — Beit designs and implements an algorithm for solving a relevant NP-complete class of problems using Quantum Computers, getting speedups better than quadratic, guaranteed by theory. Beit focuses on Hamiltonian cycle problem. NP-complete problems are abstractions relevant for many real world problems encountered in logistics, manufacturing, andwarehousing at scale.Beit is headquartered in Kraków, Poland.
- Paddle — Increase revenue, reduce risk and reduce cost with Paddle, the payment solution powering global revenue for n8n, Letterboxd & AdGuard. One platform that handles billing, tax and compliance.
- how.fm — Training software for better onboarding processes and digital store floor management. Train staff with no effort and language barriers.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 104
- Round size: Seed $196k–$3.1M; Series A $1.3M–$5.2M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 183
- Round size: Seed $326k–$4M; Pre-Seed $100k–$1.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Product Guru — Although there has been a significant change of pace in the technology used within the retail sector, the process of finding the products that drive the market has really remained at a stand-still. With more and more small, specialist suppliers driving innovation in the sector, it has been harder than ever for buyers to be able to consider alloptions.
- Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 18
- Round size: Seed $458k–$880k
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
- DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 76
- Round size: Seed $2M–$18M; Series A $3.3M–$10M
- Lead/follow: 66% lead, 34% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1231
- Round size: Seed $1.1M–$17M; Series A $6M–$101M; Series B $16M–$125M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
- SolveAI —
- Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 285
- Round size: Seed $1.4M–$11M; Series A $2.3M–$18M; Series B $4.2M–$45M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $66M in 2022
Portfolio highlights
- Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
- Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
- Atana Elements — Atana is a data-driven resource company that accelerates the exploration and development of flowing critical minerals.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $152k–$2.4M; Series A $2M–$15M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 61
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$9.1M; Series A $5.7M–$28M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 215
- Round size: Seed $327k–$3.1M; Series A $1.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 206
- Round size: Seed $393k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Oxa — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 208
- Round size: Seed $39k–$2.1M; Series A $295k–$10M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
- NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
- Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 243
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$60M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Unifyr — IDC MarketScape Leader 2025. AI-native PRM platform for partner onboarding, enablement, deal registration, and through-channel marketing.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 198
- Round size: Series A $3.7M–$100M; Series B $15M–$114M; Series C $22M–$175M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
- Addition Therapeutics — Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology. This approach enables the precise insertion of genetic elements at specific safe harbor sites, aiming to transform the field of genetic medicine. They operate within the biotechnology industry and are backed by venture capital. Their innovativemethods target gene editing and regulation, potentially offering new solutions in the field of genetic therapies.
- Morphic Therapeutic — Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 50
- Round size: Seed $531k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Hong Kong
Investor stats
- Total investments: 41
- Round size: Seed $1.3M–$12M; Series A $17M–$61M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
WE BACK HEROES using technology to solve the world's biggest problems
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 184
- Round size: Seed $2M–$15M; Series A $8.5M–$37M; Series B $16M–$91M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
- Onepot.ai — Search 2.7 billion make-on-demand analogs from onepot CORE, get a quote, and we synthesize and QC them in our US-based lab. AI-powered custom synthesis CRO.
- Adaption Labs — Adaptation creates AI systems that adjust to changing real-world circumstances.
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 100
- Round size: Seed $2.5M–$31M; Series A $2M–$73M; Series B $8.5M–$65M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
- Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
- BeyondMath — AI-first approach to simulating the physical world
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 141
- Lead/follow: no public data
Portfolio highlights
- Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
- Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
- FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 70
- Round size: Series A $5.5M–$51M; Series B $21M–$105M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Seed, Angel
- Geography: United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $79k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
- Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
- Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1M–$12M; Series A $7.3M–$26M; Series B $15M–$53M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
- Mantle — Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping.
- CryptoNumerics — HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists ofengineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.
We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, Hungary
Investor stats
- Total investments: 31
- Round size: Seed $1.3M–$9.2M; Series A $5.1M–$30M; Series B $15M–$100M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
- Agile Analog — Agile Analog is a company with a mission to transform the landscape of the Analog IP market space.
- Athernal Bio — Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Northern Gritstone is an investment firm focused on investing in advanced materials, energy, health technology and cognitive computation.
Show more...Investment focus
- Industry: Software, Electronics, Health Care
- Stage:Seed, Series A, Series D
- Geography: United Kingdom, Singapore
Investor stats
- Total investments: 37
- Round size: Seed $2.4M–$7.3M; Series A $2.5M–$27M; Series D $42M–$229M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- AmpliSi —
- Iceotope — Iceotope has developed technology with a blank drawing board and an open mind. So when we look at conventional problems, we find unconventional solutions.Built around our liquid-cooling approach and shaped by an extensive portfolio of patents, we’ve proven what our technology can do for HPC and data centre applications - dramatically reducingenergy consumption, space and noise. But it’s just the start. We’re going to keep innovating, working toward a day when wasteful, inefficient air-cooling is a thing of the past. We have created a business to look forward, but we’re also proud of the heritage that British engineering is built on. Iceotope is delighted to own the Made in Sheffield mark to show our dedication to the area’s tradition of engineering excellence. With decades of technical, design and engineering experience, we’ve established Iceotope as a trusted partner at the forefront of liquid-cooling technology. Now we’re investing to make sure we stay there: refining our designs, improving performance and engineering new applications.
- Imperagen — Imperagen combines AI, QM/physics-based simulations, and high throughput lab testing to deliver true, verified enzyme improvements faster with lower cost.
Discovery Park is a thriving UK science park offering state-of-the-art lab space to rent and modern offices in Kent.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Energy
- Stage:Non-Equity Assistance, Pre-Seed, Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 15
- Round size: Pre-Seed $391k–$1.7M
- Lead/follow: 87% lead, 13% follow
Portfolio highlights
- MilaK — MilaK is using the latest biotechnology and precision fermentation to make next-generation products that help with immune and metabolic function, recovery, and long-term health. These products will make nutrition smarter, cleaner, and more accurate.
- BlokBio — BlokBio offers AI-driven tools for efficient genomic data analysis and workflow automation in biotechnology research.
- Veirulence — Virulence is creating a new class of antibacterial drugs called therapies that target virulence factors (VF).
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 400
- Round size: Seed $2.1M–$12M; Series A $3.3M–$22M; Series B $8M–$44M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $101M in 2019
Portfolio highlights
- geoSurge — Customers don't search. They ask.
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 578
- Round size: Seed $131k–$2.2M; Pre-Seed $173k–$846k
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
- Furbnow — Furbnow - Your companion for home improvements for the future
- Checkboard — Complete your identity verification and payments without the paperwork. Checkboard handles your ID, open banking, and payments from one app.
Playfair is a sector agnostic fund focused exclusively on pre-seed investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making six investments a year out of its third $70m fund and preserving time, capital and resource to help companies post-investment. Our 78% Series Agraduation rate is ~3x industry average. Playfair has backed 100+ companies since 2013, including Thought Machine, Orca AI, Protex AI, StackOne and Nory.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 147
- Round size: Seed $1.2M–$7.6M; Pre-Seed $700k–$3.1M; Series A $2.7M–$18M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
- Astral Systems — Our compact multi-state fusion reactors offer high particle flux and exceptional lifetime performance, unlocking a wide variety of critical medical, industrial, and research applications today.
- Exclaim Robotics — Autonomous mobile robots for the AI data center.
Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the businesslifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 230
- Round size: Series A $3.2M–$31M; Series B $7.9M–$60M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $6.1M in 2011
Portfolio highlights
- Perkbox — Discover a global employee benefits and rewards platform. Perkbox delivers perks, wellbeing, and engagement tools to help your teams thrive worldwide.
- MAIA Technology — MAIA is a front-to-back asset management technology suite born out of an established asset management business with the pedigree of a decade of development and refinement.
- Mobile Travel Technologies — Mobile Travel Technologies (MTT) is the leading mobile travel technology specialist for airlines, hotels and travel intermediaries with an extensive customer base across the global travel industry.MTT’s advanced mobile travel platform powers some of the most successful and highest revenue generating mobile channels in the travel industry. As apioneer in this space having first launched mobile bookings for airlines in 2006, MTT has remained a first mover in mobile travel and has picked up many awards along the way for its successful, customer focused travel apps & mobile sites. MTT offers its clients unrivalled travel industry expertise, world-class mobile development, creative design, mobile usability expertise and a sophisticated mobile travel platform. MTT clients include Saudi Arabian Airlines (Saudia), the flag carrier for Kingdom of Saudi Arabia, LAN Airlines in Chile and TAM Airlines in Brazil (the LATAM Airlines Group), easyJet, transavia.com of the Air France KLM Group, Flybe, Jumeirah Group and Atlantis The Palm, Dubai.
We build relationships early, make decisions quickly, but engage with you for the long term. Our focus is getting B2B software companies at Pre-Seed and Seed to a successful Series A.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 147
- Round size: Seed $1M–$5.6M; Pre-Seed $1M–$4M; Series A $5.1M–$20M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- sable bio — We provide comprehensive, quantified, and flexible Target Safety Intelligence to assist toxicologists, informaticians, and drug discovery scientists in delivering safe and effective new treatments.
- SimplyCook — SimplyCook offers home recipe kits with easy step-by-step guides to cook restaurant-quality food in less than 20 minutes.SimplyCook boxes contain 4 easy to follow recipes and 4 ingredient kits. Each kit is designed to provide perfect taste-containing ingredient blends devised by professional chefs.
- SwiftShift — We are America's only Care Team Managed home health company empowering nurses and aides with control and autonomy over their home care efforts, instead of treating them like robots who work shift to shift.
Pentech Ventures is a venture capital fund focused on finding category defining software companies. Their passion is helping founders develop their startup into an internationally successful organisation. They have done this multiple times, partnering with leading VCs, corporations and investment banks along the way. They consider any opportunitycapable of becoming a market leader but are most comfortable being the first venture investor, supporting founders through the early stages of proving product and market fit. Their initial investment is likely to be £500K to £2M, with up to £10M invested over the lifetime of the investment.They invest in founders who are ambitious to build a global company, have the passion and ability to attract the best team and who are focused on the data and understand the key drivers in proving and building their business. They support the founders they invest in to develop and grow with their business.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Series A, Series B
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 80
- Round size: Series A $1.3M–$17M; Series B $3.7M–$60M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $119M in 2017
Portfolio highlights
- nPlan — AI that forecasts project outcomes, creates scenarios of the future and helps mitigate risk across single projects and portfolios. Trained on over 750,000 past programmes.
- Causaly — Causaly is the fastest way to find evidence, explore hidden connections and make new predictions in biomedical science
- Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 79
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Longas — Longas Technologies, a Next Generation Sequencing (NGS) technology developer, has provided details on its Morphoseq™ library prep and associated software technology at the ‘Sequencing, Finishing and Analysis.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
Ada Ventures is a pre-seed inclusive venture capital firm that invests in the best, not just the best-connected. They find and fund the Ada Lovelaces of today. Backing European founders building businesses for a better human future. They invest £250K - £1M in technology companies across climate equity, economic empowerment and healthy ageing. Adainvests in purpose-led founders building for markets that are large, untapped and growing. Their approach drives outperformance, which they call Inclusive Alpha®.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Denmark, Ireland
Investor stats
- Total investments: 76
- Round size: Seed $1.3M–$6.8M; Pre-Seed $507k–$1.4M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Tyred — Tyred is revolutionising micromobility with a service philosophy built in three core pillars: simplicity, convenience, and scalability.
- Interfaze — JigsawStack provides fine-tuned custom models that do the heavy lifting for APIs in every tech stack and helps ship faster.
- Cascade — Cascade is an AI platform that helps engineering, architecture, and construction firms predict upcoming projects and automatically find, score, and write proposals for high‑fit contracts, so they can win more work with less manual effort.
Life Science VC funding in United Kingdom at a glance
Stats across 589 deals from 662 investors.
Access all 662 VC funds in United Kingdom Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 662 VC funds investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!